Shares of Pediatrix Medical Group (MD) plummeted 5.25% in Friday's intraday trading session, underperforming the broader market.
The decline in Pediatrix Medical's stock price appears to be driven by multiple analysts lowering their price targets for the company. Truist Securities adjusted its price target for MD from $15 to $18, maintaining a Hold rating. Similarly, Deutsche Bank lowered its target price from $15 to $17 while keeping a Hold rating.
Despite the downward revisions, analysts polled by FactSet still maintain an average overweight rating on Pediatrix Medical with a mean price target of $17.93, indicating potential for upside from the current stock levels.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。